Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?. Issue 5 (11th May 2021)

Record Type:: Journal Article
Title:: Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?. Issue 5 (11th May 2021)
Main Title:: Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
Authors:: Marinoni, Ilaria
Abstract:
Is Part Of:: Gut. Volume 71:Issue 5(2022)
Journal:: Gut
Issue:: Volume 71:Issue 5(2022)
Issue Display:: Volume 71, Issue 5 (2022)
Year:: 2022
Volume:: 71
Issue:: 5
Issue Sort Value:: 2022-0071-0005-0000
Page Start:: 847
Page End:: 848
Publication Date:: 2021-05-11
Subjects:: pancreatic endocrine tumour -- neuroendocrine cells -- neuroendocrine tumors -- pancreatic islet cell
Gastroenterology -- Periodicals
616.33
Journal URLs:: http://gut.bmjjournals.com ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/gutjnl-2021-324664 ↗
Languages:: English
ISSNs:: 0017-5749
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 26372.xml